深入研究NET在儿童癌症的临床影响
Nuria Benavent1, Adela Cañete2,3, Bienvenida Argilés3
1Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain. nuria_benavent@iislafe.es.
Pediatric research
|August 2, 2024
概括
在儿科癌症中对中性粒细胞外细胞陷 (NETs) 的研究是有限的,但有希望的. 研究表明,NET可能会影响年轻癌症患者的感染风险,治疗耐药性和预后.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 儿童癌症的治疗具有挑战性,有侵略性的亚型往往对当前疗法具有抗性.
- 中性细胞外细胞陷 (NETs) 越来越多地被认为是它们在各种疾病中的作用.
- 儿童瘤学中NETs的具体参与需要进一步阐明.
研究的目的:
- 在儿童癌症的背景下,系统地审查有关中性粒细胞外细胞陷 (NETs) 的现有文献.
- 确定研究缺口,并强调NET在儿科恶性瘤中的潜在意义.
- 总结当前关于NETs对感染,治疗耐药性和儿科癌症预后的影响的研究结果.
主要方法:
- 对调查儿童癌症中NETs的研究进行系统文献综述.
- 专注于最常见的儿科癌症亚型.
- 对现有研究进行分析,以确定趋势和知识差距.
主要成果:
- 研究发现,专门针对儿科癌症中NETs的研究显著稀缺.
- 初步发现表明,NET可能在感染风险,治疗耐药性和患者的治疗结果方面发挥作用.
- 审查的研究表明,NETs与特定的儿科瘤类型之间存在潜在联系.
结论:
- 儿科癌症中NETs的领域正在芽,这强调了专门研究的必要性.
- 对NET的进一步调查可以提高对儿科癌症生物学的理解.
- 在儿科瘤学中优先考虑NET研究可能会导致改善治疗策略和患者预后.
更多相关视频
08:59Neutrophil Extracellular Traps Generated by Low Density Neutrophils Obtained from Peritoneal Lavage Fluid Mediate Tumor Cell Growth and Attachment
Published on: August 3, 2018
8.8K
09:43Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
Published on: October 14, 2019
6.5K
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
156
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
156
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K